705 related articles for article (PubMed ID: 20149882)
1. Nanoplatforms for constructing new approaches to cancer treatment, imaging, and drug delivery: what should be the policy?
Kateb B; Chiu K; Black KL; Yamamoto V; Khalsa B; Ljubimova JY; Ding H; Patil R; Portilla-Arias JA; Modo M; Moore DF; Farahani K; Okun MS; Prakash N; Neman J; Ahdoot D; Grundfest W; Nikzad S; Heiss JD
Neuroimage; 2011 Jan; 54 Suppl 1(Suppl 1):S106-24. PubMed ID: 20149882
[TBL] [Abstract][Full Text] [Related]
2. Nanomedicine-based neuroprotective strategies in patient specific-iPSC and personalized medicine.
Jang SF; Liu WH; Song WS; Chiang KL; Ma HI; Kao CL; Chen MT
Int J Mol Sci; 2014 Mar; 15(3):3904-25. PubMed ID: 24599081
[TBL] [Abstract][Full Text] [Related]
3. Targeting cancer cells with nanotherapeutics and nanodiagnostics: Current status and future perspectives.
Ali ES; Sharker SM; Islam MT; Khan IN; Shaw S; Rahman MA; Uddin SJ; Shill MC; Rehman S; Das N; Ahmad S; Shilpi JA; Tripathi S; Mishra SK; Mubarak MS
Semin Cancer Biol; 2021 Feb; 69():52-68. PubMed ID: 32014609
[TBL] [Abstract][Full Text] [Related]
4. Biomedical nanotechnology for cancer.
Pope-Harman A; Cheng MM; Robertson F; Sakamoto J; Ferrari M
Med Clin North Am; 2007 Sep; 91(5):899-927. PubMed ID: 17826110
[TBL] [Abstract][Full Text] [Related]
5. Nanotechnology and nanomedicine: going small means aiming big.
Teli MK; Mutalik S; Rajanikant GK
Curr Pharm Des; 2010 Jun; 16(16):1882-92. PubMed ID: 20222866
[TBL] [Abstract][Full Text] [Related]
6. Nanomedicine for drug delivery and imaging: a promising avenue for cancer therapy and diagnosis using targeted functional nanoparticles.
Liu Y; Miyoshi H; Nakamura M
Int J Cancer; 2007 Jun; 120(12):2527-37. PubMed ID: 17390371
[TBL] [Abstract][Full Text] [Related]
7. Nanotechnology applications in cancer.
Nie S; Xing Y; Kim GJ; Simons JW
Annu Rev Biomed Eng; 2007; 9():257-88. PubMed ID: 17439359
[TBL] [Abstract][Full Text] [Related]
8. Emerging nanomedicines for early cancer detection and improved treatment: current perspective and future promise.
Bharali DJ; Mousa SA
Pharmacol Ther; 2010 Nov; 128(2):324-35. PubMed ID: 20705093
[TBL] [Abstract][Full Text] [Related]
9. Targeted delivery system of nanobiomaterials in anticancer therapy: from cells to clinics.
Jin SE; Jin HE; Hong SS
Biomed Res Int; 2014; 2014():814208. PubMed ID: 24672796
[TBL] [Abstract][Full Text] [Related]
10. Integrating Artificial Intelligence and Nanotechnology for Precision Cancer Medicine.
Adir O; Poley M; Chen G; Froim S; Krinsky N; Shklover J; Shainsky-Roitman J; Lammers T; Schroeder A
Adv Mater; 2020 Apr; 32(13):e1901989. PubMed ID: 31286573
[TBL] [Abstract][Full Text] [Related]
11. Nanomedicine--prospective therapeutic and diagnostic applications.
Emerich DF
Expert Opin Biol Ther; 2005 Jan; 5(1):1-5. PubMed ID: 15709905
[TBL] [Abstract][Full Text] [Related]
12. Perspectives and potential applications of nanomedicine in breast and prostate cancer.
Liu Y; Solomon M; Achilefu S
Med Res Rev; 2013 Jan; 33(1):3-32. PubMed ID: 23239045
[TBL] [Abstract][Full Text] [Related]
13. Nanotechnology: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2006; 6(19):1-43. PubMed ID: 23074489
[TBL] [Abstract][Full Text] [Related]
14. Toward the emergence of nanoneurosurgery: part II--nanomedicine: diagnostics and imaging at the nanoscale level.
Leary SP; Liu CY; Apuzzo ML
Neurosurgery; 2006 May; 58(5):805-23; discussion 805-23. PubMed ID: 16639314
[TBL] [Abstract][Full Text] [Related]
15. Synthetic Lethality: From Research to Precision Cancer Nanomedicine.
Gupta A; Ahmad A; Dar AI; Khan R
Curr Cancer Drug Targets; 2018; 18(4):337-346. PubMed ID: 28669337
[TBL] [Abstract][Full Text] [Related]
16. Recent insights in nanotechnology-based drugs and formulations designed for effective anti-cancer therapy.
Piktel E; Niemirowicz K; Wątek M; Wollny T; Deptuła P; Bucki R
J Nanobiotechnology; 2016 May; 14(1):39. PubMed ID: 27229857
[TBL] [Abstract][Full Text] [Related]
17. Nanomedicine and drug delivery.
Wei C; Wei W; Morris M; Kondo E; Gorbounov M; Tomalia DA
Med Clin North Am; 2007 Sep; 91(5):863-70. PubMed ID: 17826106
[TBL] [Abstract][Full Text] [Related]
18. Advances in refunctionalization of erythrocyte-based nanomedicine for enhancing cancer-targeted drug delivery.
Sun D; Chen J; Wang Y; Ji H; Peng R; Jin L; Wu W
Theranostics; 2019; 9(23):6885-6900. PubMed ID: 31660075
[TBL] [Abstract][Full Text] [Related]
19. Nanotechnology platforms and physiological challenges for cancer therapeutics.
Kim KY
Nanomedicine; 2007 Jun; 3(2):103-10. PubMed ID: 17442621
[TBL] [Abstract][Full Text] [Related]
20. Toward personalized cancer nanomedicine - past, present, and future.
Stegh AH
Integr Biol (Camb); 2013 Jan; 5(1):48-65. PubMed ID: 22858688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
